Clarification on precision criteria to derive sample size when designing pediatric pharmacokinetic studies

J Clin Pharmacol. 2012 Oct;52(10):1601-6. doi: 10.1177/0091270011422812. Epub 2011 Dec 12.

Authors

Yaning Wang¹, Pravin R Jadhav, Mallika Lala, Jogarao V Gobburu

Affiliation

¹ Division of Pharmacometrics, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration. Yaning.Wang@fda.hhs.gov

PMID: 22162537
DOI: 10.1177/0091270011422812

No abstract available

MeSH terms

Adolescent
Child
Child, Preschool
Clinical Trials as Topic*
Humans
Infant
Models, Biological*
Pharmacokinetics*
Sample Size